Joseph Grizzanti, DO
Allergy & Immunology · Hawthorne, NJNPI 1932107554
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $51,270 of the $79,092 with a category attached, or 64.8%. Boehringer Ingelheim accounts for 80.2% of it on its own, with 34 other manufacturers making up the rest. Among allergy & immunology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 483 payments — averaging $163.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$63K
- AstraZeneca$8K
- Mallinckrodt Hospital Products Inc.$3K
- CSL Behring$1K
- GSK$602
- Sanofi$421
- plus $3K from 29 others
Across 26 payments — averaging $2690.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mallinckrodt Enterprises LLC$37K
- Mallinckrodt Hospital Products Inc.$33K
What the payments were for
- Consulting fees$13,15317%
- Speaking & faculty fees$51,27065%
- Travel & lodging$5,3637%
- Food & beverage$8,94011%
- Education$3650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 98 | $63,459 |
| AstraZeneca | 40 | $7,913 |
| Mallinckrodt Hospital Products Inc. | 36 | $3,100 |
| CSL Behring | 63 | $1,047 |
| GSK | 41 | $602 |
| Sanofi | 26 | $421 |
| Mylan Specialty L.p. | 40 | $387 |
| Pfizer | 17 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $242 |
| Regeneron Healthcare Solutions, Inc. | 17 | $241 |
| Actelion Pharmaceuticals US, Inc. | 14 | $200 |
| Insmed, Inc. | 8 | $125 |
| ANI Pharmaceuticals, Inc. | 8 | $116 |
| Grifols USA, LLC | 8 | $115 |
| Sanofi-aventis U.S. LLC | 2 | $113 |
| Octapharma USA, Inc. | 6 | $91 |
| Amgen | 5 | $86 |
| Covis Pharma GmbH | 5 | $84 |
| Sunovion Pharmaceuticals Inc. | 4 | $52 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Electromed, Inc. | 3 | $47 |
| Genentech USA, Inc. | 3 | $45 |
| Shire North American Group Inc | 3 | $43 |
| Mallinckrodt Enterprises LLC | 3 | $41 |
| Circassia Inc. | 2 | $28 |
| Alk-abello, Inc | 2 | $28 |
| United Therapeutics Corporation | 1 | $26 |
| Optinose US, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Viatris Specialty LLC | 1 | $18 |
| Verona Pharma, Inc. | 1 | $17 |
| Invivyd Inc | 1 | $17 |
| Biocryst US Sales Co., LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Gilead | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$79,092 in reported general payments places this provider in the 90th percentile of 135 allergy & immunology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 49 | $667,951 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 33 | $292,785 |
| ArikayceAmikacin Liposomal/Neb.Accessr | 12 | $182,991 |
| Dupixent PenDupilumab | 28 | $165,780 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 121 | $104,829 |
| AlvescoCiclesonide | 120 | $95,144 |
| Qvar RedihalerBeclomethasone Dipropionate | 181 | $80,832 |
| Dupixent SyringeDupilumab | 16 | $77,778 |
| SymbicortBudesonide/Formoterol Fumarate | 213 | $71,130 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 196 | $56,823 |
| DuleraMometasone/Formoterol | 76 | $40,551 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 128 | $31,495 |
| Pulmicort FlexhalerBudesonide | 46 | $19,508 |
| Spiriva RespimatTiotropium Bromide | 21 | $15,284 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $14,147 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat | $63,459 | $683,23570 claims |
| CSL BehringHizentra | $1,047 | $292,78533 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Pulmicort Flexhaler | $7,913 | $195,467380 claims |
| Insmed, Inc.Arikayce | $125 | $182,99112 claims |
| Covis Pharma GmbHAlvesco | $84 | $95,144120 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $47 | $80,832181 claims |
| GSKBreo Ellipta, Arnuity Ellipta | $602 | $18,19738 claims |
| PfizerEliquis, Paxlovid | $255 | $11,55838 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 135 allergy & immunology providers in New Jersey.
Other allergy & immunology in Hawthorne
- Ellen SherOcean$1M
- Peter RickettiTrenton$457K
- John KimMedford$339K
- Tina ZeccaLittle Silver$262K
- George BelecanechVoorhees$208K
- Jacqueline RossOcean$131K
- Shirin JadidiMendham$98K
- Mark WeinsteinBelleville$88K
- Lisa BariscianoFlorham Park$78K
- Kerry LebengerBerkeley Heights$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.